Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Various methods have been used to identify substrate of persistent atrial fibrillation (PeAF) including complex fractionated atrial electrograms (CFAEs), electrogram dispersion, and low-voltage areas (LVAs). This study aims to investigate their relationship and changes following ablation.

Methods And Results: Consecutive patients with PeAF undergoing catheter ablation were prospectively recruited. High-density left atrial mapping was employed. Repeat mapping was performed after pulmonary vein and posterior wall isolation (PVI + PWI) if atrial fibrillation persisted. Dispersion tags were automatically annotated using a commercially available artificial intelligence system. A total of 32 patients (mean age 64.8 ± 9.7 years, 26 male) were included. In CFAE regions, 93.1 ± 7.5% of the surface had voltage > 0.5 mV, compared to only 17.5 ± 24.5% in the non-CFAE regions. Nearly all dispersion tags (99.3 ± 1.6%) were located within CFAE regions. Postablation mapping (N = 24) revealed a reduction in both CFAE and dispersion tags, prolongation of atrial cycle length, and de-escalation of CFAE sub-types, even in areas remote from ablation targets. During a median follow-up period of 9.0 ± 1.9 months, among the nine patients with CFAE de-escalations across all five regions, only one (11.1%) experienced recurrence. In contrast, eight out of the remaining 15 patients (53.3%) experienced recurrence (p = 0.039).

Conclusion: Dispersion is associated with CFAEs, predominantly reflecting areas of normal voltage. Regional reductions in CFAE and dispersion burden may occur outside of the directly targeted ablation areas. Post-procedural de-escalation of electrograms across the left atrium might suggest a potential indicator for PVI + PWI responders; however, further studies are warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.16738DOI Listing

Publication Analysis

Top Keywords

atrial fibrillation
12
dispersion tags
12
complex fractionated
8
fractionated atrial
8
atrial electrograms
8
persistent atrial
8
cfae regions
8
cfae dispersion
8
experienced recurrence
8
atrial
7

Similar Publications

Importance: Patients with kidney failure (KF) receiving long-term dialysis have increased incidence of atrial fibrillation (AF). Patients with KF and AF have increased risk of stroke, death, and bleeding compared with age-matched cohorts. In KF, the use of oral anticoagulants (OACs) increases hemorrhage risk, offsetting potential benefits and making left atrial appendage occlusion (LAAO) a potentially promising solution for risk reduction in AF.

View Article and Find Full Text PDF

Aim: This study aimed to establish general consensus on a systematic needs assessment model to determine eligibility for cardiac rehabilitation (CR) as part of secondary prevention in individuals with atrial fibrillation (AF). Specific objectives included identifying relevant needs assessment criteria and establishing consensus on referral criteria.

Methods: A Delphi study was conducted following the ACCORD guidelines (ACcurate COnsensus Reporting Document) with participation of an international, multi-disciplinary expert panel including physicians, nurses and other healthcare professionals, across primary and secondary care as well as academic research.

View Article and Find Full Text PDF

Objectives: Proton pump inhibitors (PPIs) are commonly used among these patients to prevent upper gastrointestinal bleeding (UGIB) in anticoagulated patients. However, their clinical benefits among patients receiving OACs with a history of UGIB remain inconclusive. This study aimed to summarize the clinical benefits of PPIs for the secondary prevention of recurrent UGIB among patients using OACs.

View Article and Find Full Text PDF

Background: Tachycardia-induced cardiomyopathy (TICM) is typically reversible with rhythm control, but individual susceptibility remains poorly understood and may reflect genetic predisposition.

Case Summary: A 66-year-old woman with paroxysmal atrial fibrillation (AF) presented with new-onset heart failure. Genetic testing identified a likely pathogenic heterozygous ABCC9 gene variant (c.

View Article and Find Full Text PDF